|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-10-1
|
|
pubmed:abstractText |
To investigate the level of nerve growth factor (NGF) mRNA in bladder tissue and the effect of botulinum toxin A (BTX-A) treatment in patients with interstitial cystitis (IC).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
463-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17905097-Administration, Intravesical,
pubmed-meshheading:17905097-Adult,
pubmed-meshheading:17905097-Afferent Pathways,
pubmed-meshheading:17905097-Aged,
pubmed-meshheading:17905097-Botulinum Toxins, Type A,
pubmed-meshheading:17905097-Combined Modality Therapy,
pubmed-meshheading:17905097-Cystitis, Interstitial,
pubmed-meshheading:17905097-Dilatation,
pubmed-meshheading:17905097-Female,
pubmed-meshheading:17905097-Humans,
pubmed-meshheading:17905097-Male,
pubmed-meshheading:17905097-Middle Aged,
pubmed-meshheading:17905097-Nerve Growth Factor,
pubmed-meshheading:17905097-Neurogenic Inflammation,
pubmed-meshheading:17905097-Pain,
pubmed-meshheading:17905097-Protein Precursors,
pubmed-meshheading:17905097-RNA, Messenger,
pubmed-meshheading:17905097-Water
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis.
|
|
pubmed:affiliation |
Department of Urology, Buddhist Tzu Chi General Hospital and Buddhist Tzu Chi University School of Medicine, Hualien, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Controlled Clinical Trial
|
